ALLMedicine™ Parathyroid Hormone Center

Jun 26th, 2022 - We previously reported that modified-release nicotinamide (NAMR) was superior to placebo in reducing serum phosphate concentrations over 12 weeks in a large cohort of haemodialysis patients with hyperphosphataemia. Here, we report outcomes after 5...

Jun 25th, 2022 - The objective of this study was to analyze vitamin D status and PTH concentrations in 6- to 8-year-old girls with central precocious puberty. A cross-sectional clinical and blood testing study (calcium, phosphorus, 25(OH)D and PTH) was carried out...

Jun 25th, 2022 - Bariatric surgery remains an effective treatment for the condition of obesity. However it predisposes patients to nutritional deficiencies and related complications. The aim of this study was to identify nutritional abnormalities, weight loss, adh...

Jun 25th, 2022 - Hip fragility fractures are becoming one of the main health care problems in countries with an aging population. This study aimed to evaluate the clinical characteristics and the usefulness of bone turnover markers in patients with a hip fracture....

Jun 24th, 2022 - Familial multiple endocrine neoplasia type 1 (MEN1), familial hypocalciuric (or familial benign) hypercalcemia (FHH), hyperparathyroidism - jaw tumor syndrome (HPT-JT), other causes of familial isolated hyperparathyroidism (FIHP), and pseudohypopa...

Nov 20th, 2021 - Hyperparathyroidism is defined as excessive parathyroid hormone production. The diagnosis is made through biochemical testing, in which imaging has no role. However, imaging is appropriate for preoperative parathyroid gland localization with the i...

Nov 2nd, 2019 - In children with chronic kidney disease (CKD), optimal control of bone and mineral homeostasis is essential, not only for the prevention of debilitating skeletal complications and achieving adequate growth but also for preventing vascular calcific...

Jul 24th, 2018 - 25(OH)D = 25-hydroxyvitamin D; BMD = bone mineral density; CV = cardiovascular; GI = gastrointestinal; IOM = Institute of Medicine; PTH = parathyroid hormone; RCT = randomized controlled trial; αTF = α-tocopherol; ucOC = undercarboxylated osteocal...

Jun 1st, 2018 - Hypoparathyroidism (hypoPT) is the most common complication following bilateral thyroid operations. Thyroid surgeons must employ strategies for minimizing and preventing post-thyroidectomy hypoPT. The objective of this American Thyroid Association...

Sep 24th, 2016 - AACE = American Association of Clinical Endocrinologists AFF = atypical femur fracture ASBMR = American Society for Bone and Mineral Research BEL = best evidence level BMD = bone mineral density BTM = bone turnover marker CBC = complete blood coun...

Jun 24th, 2022 - This clinical study aims to evaluate the safety and efficacy of repeated dosing of recombinant human parathyroid hormone (rhPTH[1-84]) in Japanese participants with chronic hypoparathyroidism for a 26-week period.

Jun 24th, 2022 - Patients with confirmed or suspected states with resistance to vitamin D or parathyroid hormone (PTH) will be admitted for diagnosis, treatment review with suggestions for modifications to the current or new treatment and for inclusion in other pr...

Jun 24th, 2022 - Background Canagliflozin is a new oral drug for the treatment of type 2 diabetes mellitus (T2DM), and is one of four recently FDA approved sodium glucose co-transporter 2 (SGLT2) inhibitors, which target renal glucose reabsorption and offer promis...

Jun 24th, 2022 - Familial multiple endocrine neoplasia type 1 (MEN1), familial hypocalciuric (or familial benign) hypercalcemia (FHH), hyperparathyroidism - jaw tumor syndrome (HPT-JT), other causes of familial isolated hyperparathyroidism (FIHP), and pseudohypopa...

Jun 23rd, 2022 - Participants of this study are women in the third semester of pregnancy, who consented to be included with their babies in this study. Firstly, the parents will be given explanation regarding the study, and informed consent will be signed if they ...

Oct 27th, 2021 - SGLT-2 inhibitors were deemed safe for the bones in older patients with type 2 diabetes, a new study reassured. No significant differences were seen in regards to fracture risk when comparing new SGLT-2 inhibitor users versus new DPP-4 inhibitor u...

Oct 11th, 2021 - An investigational oral form of parathyroid hormone (PTH 1-34), EB 613 (Entera Bio Ltd) met its primary efficacy outcome in a phase 2 dosing study involving postmenopausal women with low bone mineral density (BMD). The adverse effect profile of th...

Sep 15th, 2021 - NEW YORK (Reuters Health) - In adults with chronic hypoparathyroidism, an investigational prodrug of parathyroid hormone, TransCon PTH, allowed most participants in a small randomized trial to reduce or forgo conventional therapy of vitamin D and ...

Jun 22nd, 2021 - The Diagnosis: Platelike Osteoma Cutis Histopathologic examination revealed extensive cutaneous ossification in the dermis and subcutis with dermal fibrosis and minimal surrounding inflammation (Figure 1). There was no evidence of infection or neo.

May 18th, 2021 - Non-calcium-based phosphate binders weren't any better at reducing cardiovascular events than calcium-based binders in dialysis patients, the LANDMARK trial determined. In the open-label randomized trial of over 2,300 Japanese patients on hemodial...